.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to ...
.Aelis Farma's chances of safeguarding a simple, favorable choice on a $one hundred million option s...
.ProKidney has stopped among a set of period 3 trials for its cell therapy for renal ailment after d...
.Vaxcyte revealed what analysts named "impressive" phase 1/2 information for its 31-valent pneumococ...
.Recursion has stumbled by means of a very early exam of its tech-enabled approach to medicine explo...
.Contact it a scenario of excellent chemical make up: Acepodia, a biotech based on Nobel Champion sc...
.Praxis Preciseness Medicines has racked up yet another midphase succeed in epilepsy this year, with...
.After running away a clinical hold numerous years back, Dyne Therapy has actually uncovered new per...
.Arrowhead Pharmaceuticals has shown its own hand in advance of a possible showdown with Ionis, post...
.Pfizer and also Valneva may possess about two even more years to stand by prior to they help make t...